These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. Tuchman M, Hee A, Emeribe U, Silberstein S. CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280 [Abstract] [Full Text] [Related]
10. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team. Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [Abstract] [Full Text] [Related]
12. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany. Diener HC, Gendolla A. Curr Med Res Opin; 2005 Jan; 21 Suppl 3():S18-24. PubMed ID: 16083520 [Abstract] [Full Text] [Related]
13. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157 [Abstract] [Full Text] [Related]
15. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older. McKeage K. Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634 [Abstract] [Full Text] [Related]
16. Clinical applications of new therapeutic deliveries in migraine. Dahlöf C. Neurology; 2003 Oct 28; 61(8 Suppl 4):S31-4. PubMed ID: 14581656 [Abstract] [Full Text] [Related]
17. Myalgia and cramps associated with zolmitriptan. Alonso-Navarro H, Jiménez-Jiménez FJ. Clin Neuropharmacol; 2005 Oct 28; 28(5):241-2. PubMed ID: 16239765 [Abstract] [Full Text] [Related]
19. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial. Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S. Curr Med Res Opin; 2005 Mar 28; 21(3):381-9. PubMed ID: 15811207 [Abstract] [Full Text] [Related]
20. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Geraud G, Compagnon A, Rossi A, COZAM Study Group. Eur Neurol; 2002 Mar 28; 47(2):88-98. PubMed ID: 11844897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]